TAZ 抗体
(Tafazzin (TAZ))
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced\; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| TAZ 抗体 (AA 1-262) | 人 | 小鼠 Monoclonal |
|
|
|
| TAZ 抗体 (AA 1-100) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 32-60) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 95-262) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 46-240) | 小鼠 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-262) | 人 | 小鼠 Monoclonal |
|
|
|
| TAZ 抗体 (AA 154-292) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 174-248) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 192-241) | 人, 小鼠, 大鼠, Cow, 猴, 兔, 犬, Bat | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 46-239) | 大鼠 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-262) | 人 | 小鼠 Monoclonal |
|
|
|
| TAZ 抗体 (C-Term) | 人 | 山羊 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-100) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-100) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-100) (PE) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-100) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| TAZ 抗体 (AA 1-100) (Cy5.5) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
3 references - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1B10
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1-262
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB21836
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 32-60, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 32-60
Primary Antibody
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 95-262
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 46-240
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3C10
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1-262
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 154-292
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 174-248
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 46-239
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4A10-H3
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 抗原表位
- AA 1-262
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 1-100
Latest Publications for our TAZ 抗体
: "Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells." in: Journal of cellular biochemistry, Vol. 117, Issue 6, pp. 1419-28, (2016) (PubMed).
: "Prognostic impact of TAZ and ?-catenin expression in adenocarcinoma of the esophagogastric junction." in: Diagnostic pathology, Vol. 9, pp. 125, (2014) (PubMed).
: "Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells." in: PLoS ONE, Vol. 9, Issue 10, pp. e109811, (2014) (PubMed).
: "Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ." in: Investigative ophthalmology & visual science, Vol. 54, Issue 1, pp. 378-86, (2013) (PubMed).
: "Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells." in: Experimental eye research, Vol. 113, pp. 66-73, (2013) (PubMed).
: "Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts." in: Stem cells and development, Vol. 18, Issue 8, pp. 1211-20, (2009) (PubMed).
: "TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation." in: Cell cycle (Georgetown, Tex.), Vol. 5, Issue 2, pp. 176-9, (2006) (PubMed).
: "Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins." in: The Journal of cell biology, Vol. 174, Issue 3, pp. 379-90, (2006) (PubMed).
: "TAZ, a transcriptional modulator of mesenchymal stem cell differentiation." in: Science (New York, N.Y.), Vol. 309, Issue 5737, pp. 1074-8, (2005) (PubMed).
: "Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome." in: Molecular biology of the cell, Vol. 16, Issue 11, pp. 5202-14, (2005) (PubMed).
: "Prognostic impact of TAZ and ?-catenin expression in adenocarcinoma of the esophagogastric junction." in: Diagnostic pathology, Vol. 9, pp. 125, (2014) (PubMed).
: "Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells." in: PLoS ONE, Vol. 9, Issue 10, pp. e109811, (2014) (PubMed).
: "Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ." in: Investigative ophthalmology & visual science, Vol. 54, Issue 1, pp. 378-86, (2013) (PubMed).
: "Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells." in: Experimental eye research, Vol. 113, pp. 66-73, (2013) (PubMed).
: "Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts." in: Stem cells and development, Vol. 18, Issue 8, pp. 1211-20, (2009) (PubMed).
: "TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation." in: Cell cycle (Georgetown, Tex.), Vol. 5, Issue 2, pp. 176-9, (2006) (PubMed).
: "Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins." in: The Journal of cell biology, Vol. 174, Issue 3, pp. 379-90, (2006) (PubMed).
: "TAZ, a transcriptional modulator of mesenchymal stem cell differentiation." in: Science (New York, N.Y.), Vol. 309, Issue 5737, pp. 1074-8, (2005) (PubMed).
: "Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome." in: Molecular biology of the cell, Vol. 16, Issue 11, pp. 5202-14, (2005) (PubMed).
Aliases for TAZ 抗体
tafazzin (TAZ) 抗体tafazzin (taz) 抗体
tafazzin L homeolog (taz.L) 抗体
tafazzin homolog (LOC550948) 抗体
tafazzin (AFUA_2G13960) 抗体
tafazzin (AOR_1_318014) 抗体
tafazzin (Tsp_06712) 抗体
tafazzin (Taz) 抗体
5031411C02Rik 抗体
9130012G04Rik 抗体
Afu2g13960 抗体
AW107266 抗体
AW552613 抗体
BTHS 抗体
CMD3A 抗体
EFE 抗体
EFE2 抗体
G4.5 抗体
GB11956 抗体
LVNCX 抗体
MGC54019 抗体
TAZ 抗体
taz 抗体
Taz1 抗体
wu:fb39f12 抗体
zgc:91803 抗体
您还需要查找其他产品吗？
You are here:
